![FACS analysis of CD261-transfected HEK-293 cells using GTX80184 DR4 antibody [DR-4-02] (PE). FACS analysis of CD261-transfected HEK-293 cells using GTX80184 DR4 antibody [DR-4-02] (PE).](https://www.genetex.com/upload/website/prouct_img/normal/GTX80184/GTX80184_20191025_AP_006_415_w_23061322_593.webp)
FACS analysis of CD261-transfected HEK-293 cells using GTX80184 DR4 antibody [DR-4-02] (PE).
DR4 antibody [DR-4-02] (PE)
GTX80184
Overview
- SupplierGeneTex
- Product NameDR4 antibody [DR-4-02] (PE) - Overexpression Validated
- Delivery Days Customer9
- Clone IDDR-4-02
- Concentration0.1 mg/ml
- FormulationLiquid
- Gene ID8797
- Target nameTNFRSF10A
- Target descriptionTNF receptor superfamily member 10a
- Target synonymsAPO2; CD261; cytotoxic TRAIL receptor; death receptor 4; DR4; TNF-related apoptosis-inducing ligand receptor 1; TRAIL receptor 1; TRAILR1; TRAIL-R1; TRAILR-1; tumor necrosis factor receptor superfamily member 10A; tumor necrosis factor receptor superfamily member 10a variant 2; tumor necrosis factor receptor superfamily, member 10a
- Protein IDO00220
- Protein NameTumor necrosis factor receptor superfamily member 10A
- Scientific DescriptionThe protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor is activated by tumor necrosis factor-related apoptosis inducing ligand (TNFSF10/TRAIL), and thus transduces cell death signal and induces cell apoptosis. Studies with FADD-deficient mice suggested that FADD, a death domain containing adaptor protein, is required for the apoptosis mediated by this protein. [provided by RefSeq, Jul 2008]
- Storage Instruction2°C to 8°C
- UNSPSC12352203
References
- Genetically Modified DR5-Specific TRAIL Variant DR5-B Revealed Dual Antitumor and Protumoral Effect in Colon Cancer Xenografts and an Improved Pharmacokinetic Profile. Yagolovich AV et al., 2020 Apr, Transl OncolRead more